External Review Process for Insurance Disputes

The external review process is a formal mechanism through which policyholders can challenge an insurer's final adverse benefit determination before a neutral third party — independent of the insurance company. Governed by a combination of federal law, state statutes, and accreditation standards, external review applies most visibly to health insurance disputes but extends to other lines of coverage in certain jurisdictions. This page documents the regulatory framework, procedural mechanics, classification distinctions, and common misconceptions surrounding external review across the United States.

• Definition and Scope
• Core Mechanics or Structure
• Causal Relationships or Drivers
• Classification Boundaries
• Tradeoffs and Tensions
• Common Misconceptions
• Checklist or Steps
• Reference Table or Matrix

Definition and Scope

External review is the stage of the insurance dispute resolution process at which a qualified, independent organization — not the insurer — examines whether an adverse benefit determination was clinically and contractually appropriate. Under the Affordable Care Act (ACA), codified at 42 U.S.C. § 300gg-19, non-grandfathered individual and group health plans are required to offer both internal and external appeals. The external stage may only be initiated after internal appeal rights have been exhausted, with a limited exception for simultaneous expedited review in urgent cases.

Scope extends beyond health insurance in states that have enacted broader external review statutes. The National Association of Insurance Commissioners (NAIC) model acts — including the Uniform Health Carrier External Review Model Act — have been adopted or adapted in the majority of states, though with material variation in eligibility thresholds, covered plan types, and binding authority of decisions. For a foundational orientation to the appeals landscape, see the Insurance Appeals Process Overview.

The NAIC defines "adverse determination" to include rescissions, denials based on medical necessity, and coverage terminations. Disputes about experimental or investigational treatments are expressly included under federal external review standards published by the Department of Health and Human Services (HHS) in its interim final rules (75 Fed. Reg. 43330, 2010).

Core Mechanics or Structure

External review is administered by Independent Review Organizations (IROs), which must meet credentialing standards set by either the state, federal government, or both. Under the HHS federal external review process — applicable when a state does not have a qualifying external review law — the federal government maintains a pool of accredited IROs and assigns them on a rotating basis to avoid insurer selection bias.

Phase 1 — Eligibility Screening: The IRO or administering body confirms that the request involves a covered claim, that internal remedies have been exhausted (or that expedited processing applies), and that the request was filed within the applicable deadline. Under federal standards, the standard deadline is 4 months from receipt of the final internal denial notice (45 C.F.R. § 147.136).

Phase 3 — Clinical or Legal Review: The IRO assigns the dispute to a reviewer with relevant expertise. For medical necessity disputes, qualified professionals must be a licensed clinician in the same or similar specialty as the treating provider. Reviewers are prohibited from having financial conflicts of interest with the insurer or the claimant.

Phase 4 — Decision Issuance: Standard external review decisions must be issued within 45 calendar days of IRO receipt of the request. Expedited external review decisions — available when the standard timeframe would seriously jeopardize life, health, or ability to regain function — must be issued within 72 hours (45 C.F.R. § 147.136(d)(3)(ii)).

Phase 5 — Binding Effect: If the IRO overturns the denial, the insurer is legally required to provide coverage. Federal law makes the IRO decision binding on the plan. The claimant retains the right to pursue additional remedies — including litigation — if the IRO upholds the denial.

For disputes involving employer-sponsored plans under ERISA, the interaction between external review and federal preemption is addressed in the ERISA Appeals — Employer-Sponsored Plans resource.

Causal Relationships or Drivers

The legislative mandate for external review grew directly from documented patterns of insurer-favorable outcomes in purely internal appeals processes. The ACA's external review provisions were modeled in part on state-level experiments, particularly New York's 1998 managed care external review law — one of the first in the nation — which demonstrated statistically significant overturn rates when independent clinicians reviewed medical necessity denials.

Three structural forces drive the continued expansion of external review:

Asymmetry of information: Insurers possess detailed actuarial and clinical criteria that policyholders typically do not see until litigation or appeal. IRO access to complete claim files partially corrects this imbalance.

Conflict of interest in internal review: Internal appeal reviewers are employees or contractors of the insurer. External review eliminates that structural conflict by statute.

Regulatory consolidation: The NAIC's model acts have pushed states toward minimum standards, while the ACA created a federal floor for non-grandfathered health plans. States retain authority to impose more protective standards, which has produced a layered regulatory environment documented in Policyholder Protections by State.

Classification Boundaries

External review is not a uniform process. Four primary classification axes determine which rules apply:

1. Plan Type: Fully insured plans regulated by state law are subject to the state's external review statute. Self-funded ERISA plans are generally preempted from state external review mandates but must comply with federal external review standards under the ACA's implementing regulations.

2. Coverage Line: Health insurance external review is the most codified. Property, casualty, and life insurance external review exists in fewer than 20 states, typically through voluntary programs or limited dispute resolution schemes administered by state insurance departments.

3. Dispute Type: Medical necessity denials, rescissions, and experimental treatment denials are expressly covered under federal health insurance external review rules. Contractual interpretation disputes — where the question is what the policy language means rather than whether care was medically necessary — may fall outside IRO jurisdiction depending on state law.

4. Federal vs. State Process: When a state has a qualifying external review law (as determined by HHS), that state process applies to fully insured plans. When the state law does not qualify, the federal process under 45 C.F.R. § 147.136 governs. Grandfathered health plans are exempt from both federal external review requirements, though state law may still apply.

See Types of Insurance Appeals for a broader taxonomy of appeal categories, including how external review fits within the full dispute resolution continuum.

Tradeoffs and Tensions

Binding decisions cut both ways. The binding nature of IRO decisions protects claimants from insurer non-compliance, but it also limits recourse if the IRO upholds the denial. Unlike internal appeals, an adverse IRO decision cannot be appealed to another IRO. Litigation remains available, but courts have applied varying standards of review to post-IRO ERISA disputes.

Expedited review speed versus thoroughness. The 72-hour expedited review window is operationally compressed. IROs must render decisions with incomplete documentation in some cases, and insurers have 24 hours to transmit records under the expedited federal standard. Critics argue this creates pressure toward uphold decisions when records are ambiguous.

State variation creates coverage gaps. A policyholder in a state with a qualifying external review law and a fully insured plan may have broader rights than a policyholder in the same state with a self-funded employer plan. This structural inequality — rooted in ERISA preemption — remains unresolved at the federal level.

IRO accreditation standards are not uniform. Accrediting bodies include URAC (formerly the Utilization Review Accreditation Commission) and NCQA (National Committee for Quality Assurance). However, federal and state governments do not require uniform accreditation from a single body, and IRO quality controls vary across accreditors.

Overturn rates vary significantly by dispute type. Data published by the California Department of Managed Health Care (DMHC) — which administers one of the most transparent IRO programs in the country — shows overturn rates exceeding 40% for experimental treatment denials in some reporting periods, compared to lower overturn rates for straightforward coverage exclusion disputes. These patterns suggest that IRO intervention is not uniformly effective across all dispute categories.

Common Misconceptions

Misconception 1: External review is always available after any denial.
Correction: External review applies only to adverse benefit determinations, not to all insurance disputes. A denial based on a clear policy exclusion (e.g., an uncovered service category) may not be eligible for external review if there is no medical necessity or rescission component. Eligibility is screened by the IRO before substantive review begins.

Misconception 2: Filing for external review waives the right to sue.
Correction: Under federal law and in most state frameworks, requesting external review does not waive litigation rights. A claimant may pursue litigation after an adverse IRO decision. However, courts may consider the IRO record as part of the administrative record in ERISA cases.

Misconception 3: External review applies to all employer health plans equally.
Correction: Self-funded ERISA plans are exempt from state external review mandates. They must comply with federal external review rules under the ACA only if they are not grandfathered. Grandfathered self-funded ERISA plans face the fewest external review obligations of any plan type.

Misconception 4: The IRO reviewer is chosen by the insurer.
Correction: Under the federal external review process, IROs are assigned on a rotating basis from a federally maintained list, specifically to prevent insurer selection. State processes have similar conflict-of-interest prohibitions, though assignment mechanics vary.

Misconception 5: External review is the last possible remedy.
Correction: External review is typically the last administrative remedy before litigation. It does not foreclose filing a complaint with the state insurance department, pursuing arbitration where available, or filing suit — particularly in cases involving bad-faith insurance claims.

Checklist or Steps

The following sequence reflects the federal external review process structure as codified under 45 C.F.R. § 147.136. State processes may differ in deadline lengths, form requirements, and IRO assignment methods.

Step 1 — Receive Final Internal Denial Notice
Confirm the denial letter is labeled as a "final internal adverse benefit determination" or equivalent. The external review clock begins upon receipt of this notice.

Step 2 — Confirm Eligibility
Verify the dispute involves a covered claim type: medical necessity denial, rescission, or experimental/investigational treatment determination. Confirm the plan is not grandfathered and subject to external review requirements.

Step 3 — Identify the Governing Process
Determine whether the state has a qualifying external review law (for fully insured plans) or whether the federal process under HHS applies. For self-funded ERISA plans, confirm federal applicability.

Step 4 — Submit External Review Request Within Deadline
Under federal standards, the request must be submitted within 4 months of the final denial notice. Some state laws impose shorter windows — as few as 30 days in certain jurisdictions.

Step 5 — Cooperate with Record Requests
The IRO may request medical records, treatment notes, or supporting documentation from the claimant or treating provider. Timely submission affects the review timeline.

Step 6 — Confirm IRO Assignment and Timeline
For standard review, expect a decision within 45 calendar days. For expedited review, the decision must be issued within 72 hours of the request.

Step 7 — Receive IRO Decision
The IRO issues a written decision with reasoning. If the denial is overturned, the insurer must comply. If the denial is upheld, document the decision and preserve all records for any subsequent legal proceedings.

Step 8 — Assess Post-Decision Options
Review options including state department complaints, arbitration (where applicable per policy terms), or litigation. Consult the Insurance Arbitration vs. Appeals resource for distinction between these pathways.

Reference Table or Matrix

Key Regulatory Sources by Plan Type:

References

• 42 U.S.C. § 300gg-19 — ACA External Appeals Requirement
• 45 C.F.R. § 147.136 — Requirements for External Review (eCFR)
• 29 C.F.R. § 2560.503-1 — DOL Claims Procedure Regulation (eCFR)
• HHS External Review Interim Final Rule, 75 Fed. Reg. 43330 (2010)
• National Association of Insurance Commissioners (NAIC) — Uniform Health Carrier External Review Model Act
• California Department of Managed Health Care (DMHC) — Independent Medical Review Program
• URAC (Utilization Review Accreditation Commission)
• NCQA (National Committee for Quality Assurance)
• 29 U.S.C. § 1133 — ERISA § 503, Claims Procedure
• [HHS —